Structural basis of supercoiling-induced CRISPR–Cas9 off-target activity Nature.com 16:06 Wed, 13 May
ERS Genomics and Aurigene Sign CRISPR/Cas9 License Agreement to Advance Precision Genome Editing in Drug Discovery PR Newswire (Press Release) 13:10 Wed, 13 May
Pervasive Cas9 expression driven by mammalian promoter activity in E. coli affects representation of CRISPR sgRNA libraries Nature.com 00:22 Wed, 13 May
Students Invented a New Diagnostic for Lyme Disease — and a Tool for CRISPR Researchers Addgene 14:20 Tue, 12 May
1 Top Wall Street Analyst Thinks CRISPR Therapeutics Could More Than Double. Should You Buy the Stock Hand Over Fist? The Motley Fool 21:49 Mon, 11 May
New CRISPR RNA scissors specifically target and destroy hepatitis E virus News-Medical.Net 13:52 Mon, 11 May
CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It Zacks 15:02 Fri, 08 May
Researchers show CRISPR can selectively destroy cells, a cancer-treatment goal ecancer 15:12 Thu, 07 May
Mission Bio De-risks CRISPR-Engineered T Cells Through Single-Cell Analysis of Genomic Edits and Gene Expression Business Wire (Press Release) 14:09 Thu, 07 May
New Kind of CRISPR Could Treat Viral Infection and Cancer by Shredding Sick Cells’ DNA Newswise (Press Release) 16:02 Wed, 06 May
Researchers use CRISPR to engineer plastic eating microbe Drug Discovery & Development 22:31 Mon, 04 May
Intellia Announces Rolling BLA Submission for Lonvo-Z, CRISPR Therapy for HAE Rare Disease Advisor 20:04 Mon, 04 May
CRISPR-Cas9 Genome-Editing Approach Lowers mHTT, Improves Motor Function in HD Models Rare Disease Advisor 17:22 Mon, 04 May
JMIR News: AI Mammograms and Pocket CRISPR Lead Shift to Proactive Care Newswise (Press Release) 16:59 Thu, 30 Apr
Scribe Therapeutics to Highlight Engineered CRISPR Platform Advances and Lead Cardiometabolic Pipeline at Asgct and Eas Congress 2026 Business Wire (Press Release) 13:08 Thu, 30 Apr
What's the Next Big Thing After GLP-1 Drugs? CRISPR Therapeutics May Have the Answer. The Motley Fool 10:20 Thu, 30 Apr
Translation-dependent degradation of cas12 mRNA triggered by an anti-CRISPR Nature.com 16:22 Wed, 29 Apr
Rewiring miR-22/SNAI1 via CRISPR-based edge editing destabilizes the epithelial phenotype Nature.com 02:30 Wed, 29 Apr
Intellia Initiates Rolling BLA Submission for In Vivo CRISPR Therapy in Hereditary Angioedema JD Supra 19:04 Tue, 28 Apr
Intellia Therapeutics Pops on CRISPR Trial Success. Does That Make NTLA Stock a Buy? Barchart 19:49 Mon, 27 Apr
Intellia CRISPR drug succeeds in late-stage study against rare swelling disorder BioPharma Dive 15:17 Mon, 27 Apr
STAT Plus: Pharmalittle: We’re reading about a Lilly deal, an Intellia CRISPR rare-disease treatment, and more STAT 14:29 Mon, 27 Apr